Forest leads drug shares higher on antibiotic deal By: MarketWatch August 12, 2009 at 10:53 AM EDT Forest and AstraZeneca agree to commercialize a drug for the treatment of skin infections and a strain of pneumonia. Read More >> Related Stocks: Astrazeneca Plc ADR
